NewAmsterdam Pharma N.V. (NAMS)
NASDAQ: NAMS
· Real-Time Price · USD
26.29
-0.47 (-1.76%)
At close: Sep 25, 2025, 3:59 PM
26.29
0.00%
After-hours: Sep 25, 2025, 04:33 PM EDT
-1.76% (1D)
| Bid | 25.61 |
| Market Cap | 2.96B |
| Revenue (ttm) | 64.01M |
| Net Income (ttm) | -165.72M |
| EPS (ttm) | -1.59 |
| PE Ratio (ttm) | -16.53 |
| Forward PE | -14.9 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 27.46 |
| Volume | 535,116 |
| Avg. Volume (20D) | 935,458.9 |
| Open | 26.39 |
| Previous Close | 26.76 |
| Day's Range | 25.69 - 27.12 |
| 52-Week Range | 14.06 - 27.35 |
| Beta | -0.01 |
| Ex-Dividend Date | n/a |
About NAMS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NAMS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NAMS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNewAmsterdam Pharma N.V. is scheduled to release its earnings on
Nov 5, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+5.07%
NAMS stock has given up its prior gain. NewAmsterd...
Unlock content with
Pro Subscription
2 months ago
+5.07%
NewAmsterdam Pharma shares are trading higher. Goldman Sachs initiated coverage on the stock with a price target of $27.
1 month ago · fool.com
NewAmsterdam (NAMS) Q2 Revenue Jumps 49%NewAmsterdam (NAMS) Q2 Revenue Jumps 49%
